Many attempts have been made over the past decade to improve the *in vitro* fertilization (IVF) and *in vitro* culture (IVC) technology for mammalian embryo production. Despite significant improvements, embryos produced *in vitro* still differ from embryos produced *in vivo* because various factors for the generation of embryos are different for *in vitro* versus *in vivo* production including oxygen tension, pH, processing and interaction with sperm cells and media to which embryos are exposed \[[@r1],[@r2],[@r3]\]. One of the environmental factors that could contribute to this difference may be oxidative stress \[[@r4]\]. The level of oxidative stress has been reported to be detrimental to the fate of cells in the embryo toward proliferation, apoptosis or necrosis \[[@r5]\]. Early apoptotic death of embryos due to oxidative stress is still a commonly observed feature of porcine *in vitro* embryo-culture systems. The fragmentation in porcine embryos also thought to be related to this oxidative stress-induced apoptosis \[[@r6]\]. Today, low oxygen tension (5%) is applied to the embryo culture system to mimic the oviductal and uterine environment (2--8%). Previous studies have shown the beneficial effects of low oxygen tension on porcine embryo development compared with atmospheric oxygen (20%) \[[@r7], [@r8]\]. However, it was not sufficient to simply adjust the oxygen concentration for optimization of porcine embryo development.

Reactive oxygen species (ROS) originate both from the environment and from within the embryos as by-products of the energy metabolism pathways \[[@r9]\]. Under *in vivo* conditions, there are multiple antioxidant systems in porcine embryos, and its environment as preimplantation porcine embryos traverse the female reproductive tract and develop from the zygote to the blastocyst stage \[[@r4]\]. Embryos seem to be protected from ROS damage by the oxygen scavengers present in oviductal fluids. For example, conversion of superoxide anions into H~2~O~2~ or its removal by the activities of catalase in the cytosol and mitochondria of embryos. An imbalance between the level of intracellular ROS and the ROS scavenging capability of embryos, through antioxidants mechanisms, can lead to a state of oxidative stress. *In vitro* culture conditions and exogenous compounds can enhance the production of ROS and decrease antioxidant defenses by embryos \[[@r6]\]. Several exogenous antioxidants, such as vitamins \[[@r10]\], resveratrol \[[@r11]\], anthocyanin \[[@r12]\], and melatonin \[[@r13]\], have been added to porcine IVC medium to reduce oxidative stress in preimplantation embryos. However, there are still needs to development efficient repair systems for ROS-induced embryo damage.

Carboxyethylgermanium sesquioxide (Ge-132) is the most common water-soluble organic germanium compound which is represented by formula, ((HOOCCH~2~CH~2~Ge)~2~O~3~)*~n~*. The Ge-132 is hydrolysis product of trihalogenogermane with well-known acrylic compounds, acrylic acid or its alkyl ester \[[@r14]\]. The Ge-132 has been reported to exhibit broad spectrum of biological activities including anti-oxidative, anti-tumor, anti-inflammatory, cardiovascular activities with low toxicity \[[@r15],[@r16],[@r17]\]. Especially, the anti-oxidative function of Ge-132 can be explained by the presence of the chemical structure of Ge--C bond which make electron transfer between Ge and free radicals relatively easy and then scavenge free radicals and reduce oxidative damage \[[@r18], [@r19]\]. Recently, to improve the synergetic effect for radicals scavenging, it was used as a component of synthesized antioxidant complex with other promising pharmacologically active agents \[[@r20],[@r21],[@r22]\]. Therefore, Ge-132 has a potential to cause synergistic effects with other antioxidants known to play antioxidant roles in the development of porcine embryo \[[@r10],[@r11],[@r12],[@r13]\].

Our previous study has shown the anti-oxidative effect of Ge-132 treatment during *in vitro* maturation (IVM) on porcine oocytes by upregulating anti-oxidative related genes and downregulating proapoptotic-associated genes and improved the developmental potential of parthenogenetic and IVF porcine embryos \[[@r23]\]. However, the effect of Ge-132 treatment during preimplantation embryo development has not been investigated until now. Thus, the objective of this study was to examine the effect of Ge-132 treatment on porcine preimplantation IVF embryos during IVC. To this end, we observed embryo cleavage, blastocyst formation, intracellular levels of glutathione (GSH), and ROS, apoptotic index, mRNA (*POU5F1*, *CDX2*, *NRF2*, *KEAP1*, *BAX*, and *CASPASE3*) expression and protein (KEAP1 and BCL2) expression in porcine IVF embryos and derivation of putative embryonic stem cells (ESCs) from porcine IVF embryos.

Materials and Methods {#s1}
=====================

Chemicals
---------

Unless otherwise indicated, all chemicals and reagents used in the present study were purchased from Sigma-Aldrich (St. Louis, MO, USA).

Oocyte collection and in vitro maturation
-----------------------------------------

Ovaries of prepubertal gilts were collected at a local abattoir and transported to the laboratory within 2 h in a 0.9% (wt/vol) NaCl solution supplemented with 100 IU/l penicillin G and 100 mg/ml streptomycin sulfate at 32 to 35°C. The cumulus oocyte complexes (COCs) in the ovaries were aspirated from 3- to 6-mm diameter superficial follicles using an 18-gauge needle attached to a 10-ml disposable syringe and allowed to settle in 15-ml conical tubes at 37°C for 5 min. The supernatant was discarded, and the precipitate was resuspended in HEPES-buffered Tyrode's medium (TLH) containing 0.05% (wt/vol) polyvinyl alcohol (TLH-PVA). Next, the precipitate was examined using a stereomicroscope to recover the COCs. Only COCs with ≥ 3 uniform layers of compact cumulus cells and homogenous cytoplasm were selected and washed three times in TLH-PVA. Approximately 60 COCs were placed into each well of a four-well Nunc dish (Nunc, Roskilde, Denmark) containing 500 μl of culture medium (TCM199; Invitrogen, Carlsbad, CA, USA) supplemented with 0.6 mM cysteine, 0.91 mM sodium pyruvate, 10 ng/ml epidermal growth factor, 75 μg/ml kanamycin, 1 μg/ml insulin, 10% (vol/vol) porcine follicular fluid, 10 IU/ml equine chronic gonadotropin (eCG), and 10 IU/ml human chorionic gonadotropin (Intervet, Boxmeer, Netherlands). The selected COCs were incubated at 39°C with 5% CO~2~ in a humidified chamber for IVM. After 21 to 22 h of maturation with hormones, the COCs were washed twice in fresh hormone-free IVM medium and then cultured in hormone-free IVM medium for an additional 21 to 22 h.

In vitro fertilization and culture
----------------------------------

For *in vitro* fertilization (IVF), the COCs 42--44 h after IVM were denuded by gently pipetting with 0.1% hyaluronidase and washed three times in TLH-PVA. Groups of 15 oocytes at the metaphase II stage selected under a stereomicroscope according to the presence of the first polar body were randomly placed in 40 μl droplets of modified Tris-buffered medium (mTBM) in a 35 ×10 mm Petri dish (Falcon; Becton Dickinson Labware, Franklin Lakes, NJ, USA) covered with pre-warmed mineral oil. Next, commercial liquid semen supplied weekly from the Veterinary Service Laboratory (Department of Livestock Research, Yong-in city, Gyeonggi-do, Republic of Korea) was always stored at 17°C for 5 days before use. The semen sample was washed twice with Dulbecco's phosphate buffered saline (DPBS; Invitrogen) supplemented with 0.1% BSA (Fraction V) via centrifugation at 2000 *g* for 2 min. After washing, the sperm pellet was resuspended in mTBM \[[@r24]\], which had been pre-equilibrated for 18 h at 39°C in 5% CO~2~. After appropriate dilution, 5 μl of the sperm suspension was added to a 40 μl drop of fertilization medium (mTBM) to set the final sperm concentration at 1 × 10^6^ sperm/ml. Just before fertilization, sperm motility was assessed, and more than 80% motile sperm were used in every experiment. To use stored liquid semen, a modified two-step culture system \[[@r25]\] was applied. The oocytes were co-incubated with the sperm for 20 min at 39°C in a humidified atmosphere of 5% CO~2~ and 95% air. After 20 min of co-incubation with the sperm, the loosely attached sperm cells were removed from the zona pellucida (ZP) via gentle pipetting. Next, the oocytes were washed three times in mTBM and incubated in mTBM without sperm for 5 to 6 h at 39°C in a humidified atmosphere of 5% CO~2~ and 95% air. Thereafter, the gametes were washed three times with embryo culture medium and cultured in 25 μl microdrops (10 gametes/drop) of porcine zygote medium 3 (PZM3) \[[@r26]\] with pre-warmed mineral oil. The embryos with cultured drops were incubated at 39°C for 168 h under a humidified atmosphere of 5% O~2~, 5% CO~2~, and 90% N~2~. For all experiments, the culture media were renewed at 48 h (day 2) and 96 h (day 4) after post insemination (0 h = beginning of IVF).

Embryo evaluation and total cell count of blastocysts
-----------------------------------------------------

The day of IVF was considered day 0. The embryos were evaluated for cleavage using a stereomicroscope (Olympus SZ51, Tokyo, Japan) on day 2 (48 h). Evenly cleaved embryos were classified into three groups (2 to 3, 4 to 5, and 6 to 8 cells). Blastocyst formation was assessed on day 7 (168 h) after IVF, and blastocysts were classified according to the degree of expansion and hatching status \[[@r27]\] as follows: early blastocyst (small blastocyst with a blastocoel equal to or less than half of the embryo volume), expanded blastocyst (a large blastocyst with a blastocoel greater than half of the embryo volume or a blastocyst with a blastocoel completely filling the embryo), and hatched blastocyst (hatching or already hatched blastocyst). The percentage of early, expanded and hatched blastocysts were calculated based on total presumptive zygotes in the culture drop. To quantify the total cell number of blastocysts at day 7, the blastocysts were collected and washed in 1% (wt/vol) PBS-BSA and stained with 5 μg/ml Hoechst-33342 (bisbenzimide) for 5 min. After final wash in PBS-BSA, the embryos were fixed briefly in 4% paraformaldehyde in PBS. Next, the blastocysts were mounted on glass slides in a drop of 100% glycerol, covered gently with a cover slip, and observed using a fluorescence microscope (Nikon, Tokyo, Japan) at × 400 magnification and manually counted the total cell number of blastocysts. The experiment was repeated five times. All of the blastocysts from three of five repeats were stained for quantification of the cell number, and among them, only the embryos consisting of less than 32 cells were excluded.

Measurement of intracellular GSH and ROS levels
-----------------------------------------------

To determine the effect of Ge-132 treatment on cellular antioxidant potentials during early developmental stages, the 4- to 5- cell stage embryos derived from the IVC medium supplemented with 0, 100, 200, 400 μg/ml Ge-132 were sampled 48 h after sperm insemination for measurement of intracellular GSH and ROS levels. The GSH and ROS level assessment was performed as previously described \[[@r12], [@r28],[@r29],[@r30]\]. Briefly, 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA; Invitrogen) and 4-chloromethyl-6.8-difluoro-7-hydroxycoumarin (CellTracker Blue; CMF2HC; Invitrogen) were used to detect intracellular ROS levels (green fluorescence) and GSH levels (blue fluorescence), respectively. The H2DCFDA is a cell-permeant indicator that becomes fluorescent when oxidized by a variety of ROS. Also, the CMF2HC was used as GSH probe because it contains a chloromethyl group that reacts with thiols, probably in a glutathione S-transferase-mediated reaction, since this has been shown to occur *in vitro* \[[@r30]\]. In this study, ten embryos from each treatment group were incubated (in the dark) for 30 min in TLH-PVA supplemented with 10 μM H2DCFDA and 10 μM CellTracker Blue. After incubation, the embryos were washed with DPBS (Invitrogen) containing 0.1% (wt/vol) polyvinyl alcohol (PVA), placed into 10 μl droplets, and fluorescence was evaluated using an epifluorescence microscope (TE300; Nikon) with UV filters (460 nm for ROS and 370 nm for GSH). These fluorescent images were saved as graphic files in TIFF format. The fluorescence intensity of the embryos was analyzed using ImageJ software (Version 1.41; National Institutes of Health, Bethesda, MD, USA) and normalized to control embryos.

Gene expression analysis via quantitative real-time polymerase chain reaction (RT-PCR)
--------------------------------------------------------------------------------------

For the gene expression study, 15 expanded IVF blastocysts per group (control, 100, 200, and 400 μg/ml of Ge-132) were separately sampled using a stereomicroscope. All samples were stored at --80ºC until analyzed. The expression levels of *POU5F1*, *CDX2*, *NRF2*, *KEAP1*, *BAX*, and *CASPASE3* mRNA in the IVF blastocysts were analyzed via quantitative RT-PCR. Total RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's protocol, and the total RNA concentration was determined by measuring the absorbance at 260 nm. First-strand complementary DNA (cDNA) was prepared by subjecting 1 μg of total RNA to reverse transcription using Moloney-murine leukemia virus reverse transcriptase (Invitrogen) and random primers (9-mers; TaKaRa Bio, Otsu, Shiga, Japan). To determine the conditions for the logarithmic-phase PCR amplification of target mRNA, 1 μg aliquots were amplified using differing numbers of cycles. The housekeeping gene *GAPDH* was PCR amplified to rule out the possibility of RNA degradation and to control for the variation in mRNA concentrations in the reverse transcription reaction. A linear relationship between the PCR product band visibility and the number of amplification cycles was observed for the target mRNAs. *GAPDH* and the target genes were quantified for 40 cycles. The cDNA was amplified in a 20 μl PCR reaction containing 1 U Taq polymerase (Intron Bio Technologies, Seongnam, Korea), 2 mM deoxyribonucleoside triphosphates mix, and 10 pM of each gene-specific primer. The quantitative RT-PCR was performed on MX3000P machine (Stratagene-Agilent Technologies, Waldbronn, Germany) with 1 μl cDNA template added to 10 μl 2X SYBR Premix Ex Taq (TaKaRa Bio) containing specific primers at a concentration of 10 pM each. The reactions were carried out for 40 cycles, and the cycling parameters were as follows: denaturation at 95°C for 30 s, annealing at 55°C for 30 sec, and extension at 72°C for 30 sec. All oligonucleotide primer sequences are presented in [Table 2](#tbl_002){ref-type="table"}Table 1.Primers used for gene expression analysismRNAPrimer sequencesProduct sizeGene Bank accession number or reference(base pairs)*GAPDH*F: 5\'-GTCGGTTGTGGATCTGACCT-3\'207NM_001206359R: 3\'-TTGACGAAGTGGTCGTTGAG-5\'*POU5F1*F: 5\'-GCGGACAAGTATCGAGAACC-3\'200NM_001113060R: 3\'-CCTCAAAATCCTCTCGTTGC-5\'*CDX2*F: 5\'-GGAACCTGTGCGAGTGGATG-3\'168CK_458871R: 3\'-GCTCGGCCTTTCTCCGAATG-5\'*NRF2*F: 5\'-CCCATTCACAAAAGACAAACATTC-3\'71\[[@r60]\]R: 3\'-GCTTTTGCCCTTAGCTCATCTC-5\'*KEAP1*F: 5\'-AGCTGGGATGCCTCAGTGTT-3\'100NM001114671.1R: 3\'-AGGCAAGTTCTCCCAGACATTC-3\'*BAX*F: 5\'-TGCCTCAGGATGCATCTACC-3\'199XM_003127290R: 3\'-AAGTAGAAAAGCGCGACCAC-5\'*CASPASE3*F: 5\'-CGTGCTTCTAAGCCATGGTG-3\'186NM_214131R: 3\'-GTCCCACTGTCCGTCTCAAT-5\'Table 2.Effect of Ge-132 treatment during IVC on embryonic development after *in vitro* fertilization (IVF)Ge-132 concentration (µg/ml)No. of embryos culturedNo. of embryos developed to (% ^a^)Total cell numbers in≥ 2-cellBlastocystBlastocyst (N ^b^)0 (Control)234144 (61.6 ± 0.7) ^c,d^62 (26.5 ± 0.5) ^c^73.9 ± 6.7 (23) ^c^100233157 (67.4 ± 1.3) ^d^76 (32.6 ± 2.1) ^d^98.1 ± 7.7 (24) ^d^200234157 (67.1 ± 2.5) ^d^72 (30.8 ± 2.0) ^c,d^98.5 ± 9.3 (23) ^d^400233142 (60.9 ± 2.3) ^c^61 (26.1 ± 4.2) ^c^103.4 ± 9.3 (23) ^da^ Percentage of total cultured oocytes. ^b^Number of examined blastocysts. ^c,\ d^ Values with different superscripts within a column differ significantly (P \< 0.05). The experiment was repeated five times. The data represent the mean ± SEM.. The fluorescence intensity was measured at the end of the extension phase of each cycle. The threshold value for the fluorescence intensity of all samples was set manually. The reaction cycle at which the PCR products exceeded this fluorescence intensity threshold was deemed the threshold cycle (Ct) in the exponential phase of the PCR amplification. The expression of each target gene was quantified relative to that of the internal control gene (*GAPDH*). The relative quantification was based on a comparison of Cts at constant fluorescence intensity. The amount of transcript present was inversely related to the observed Ct and, for every twofold dilution in the amount of transcript, the Ct was expected to increase by one. The relative expression (R) was calculated using the following equation: 2^-\[ΔCt\ sample\ -ΔCt\ control\]^. To determine a normalized arbitrary value for each gene, every obtained value was normalized to that of *GAPDH*. The experiments were repeated at least three times.

Apoptosis (Annexin V and propidium iodide assay)
------------------------------------------------

To examine the effect of Ge-132 treatment on apoptosis during early developmental stages, early porcine embryos on day 2 (48 h) or day 7 (168 h) cultured with or without 200 µg/ml Ge-132 containing medium were stained using an Annexin V/ propidium iodide (PI) assay (eBioscience, San Diego, CA, USA) for apoptosis analysis, following the manufacturer's instructions. Briefly, embryos were rinsed in 1X binding buffer and incubated with annexin V (Fluorescein isothiocyanate-labeled) for 10 min at room temperature. Embryos were incubated with the PI solution for another 30 sec at room temperature, then washed in 1% (wt/vol) PBS-BSA and stained with 5 μg/ml Hoechst-33342 (bisbenzimide) for 5 min, and mounted on slides for evaluation under epifluorescence microscope (TE300; Nikon). Embryos were classified in three groups reflecting the apoptotic criteria in oocytes proposed by Anguita \[[@r31]\], representing (1) viable non-apoptotic embryos, with intact Hoechst positive nuclei and no annexin staining; (2) early apoptotic embryos with intact Hoechst positive nuclei and a homogeneous annexin positive signal in the membrane; and (3) late apoptotic or necrotic embryos which showed PI positive red nuclei, which is indicative for membrane damage. In this last group, there were occasionally signs of annexin staining in the membrane. The apoptotic index (percentage of apoptotic or necrotic cells) was obtained as the ratio of the number of apoptotic or necrotic cells relative to counted total cells following cell counting in the well-labeled areas, as determined by scanning at low magnification. The experiment was repeated three times. The total number of evaluated embryos used per group is presented in [Table 3](#tbl_003){ref-type="table"}Table 3.Effect of Ge-132 treatment to the IVC medium on the apoptotic index of Day 2 porcine embryosGroupNo. of embryos \*No. of cells (apoptotic index \*\*, %)evaluatedEarly apoptosisLate apoptosis / NecrosisevaluatedEarly apoptosisLate apoptosis / NecrosisControl2614314627 (17.1 ± 3.3) ^a^3 (2.7 ± 1.5) ^a^Ge-1323014017316 (9.1 ± 2.2) ^b^0 (0.0 ± 0.0) ^b^\* Porcine embryos cultured with or without 200 µg/ml Ge-132 containing *in vitro* culture (IVC) medium. \*\* Apoptotic index, percentage of apoptotic (Annexin V-positivie /PI-negative) or necrotic (Annexin V-positivie /PI-positive) cells in the embryos of each group. ^a,\ b^ Values with different superscripts within a column differ significantly (P \< 0.05). The experiment was repeated three times. The data represent the mean ± SEM..

Protein expression analysis via immunofluorescence staining
-----------------------------------------------------------

To observe the protein expression during Ge-132 treatment and determine the key signal pathways, porcine embryos were sampled from control (no Ge-132) and 200 μg/ml Ge-132 treatment groups at day 7 after IVF. They were fixed with 4% paraformaldehyde for 40 min, then permeabilized with 1% Triton X-100 for 30 min. After incubation in Image-iTTM FX Signal Enhancer (I36933, Invitrogen) for 30 min, the embryos were further blocked with 1% bovine serum albumin (BSA, A9418) in PBS for 1 h. They were then incubated with a primary antibody overnight at 4°C. The primary antibodies used were KEAP1 (ABS97, Millipore, Temecula, CA, 1:200) and BCL2 (SC23960, Santa Cruz, Dallas, TX, 1:200). After completely washing and secondary blocking, they were further incubated with the appropriate secondary antibodies. After the nuclei were stained with 10 µg/ml Hoechst 33342 (B2261), the embryos were mounted with anti-fade reagent (S36937, Invitrogen) and observed under laser-scanning confocal microscope (LSM700, Carl Zeiss, Oberkochen, Germany) and ZEN 2009 Light Edition software (Carl Zeiss).

Experimental design
-------------------

In experiment 1, the effect of treatments with various concentrations (0, 100, 200 and 400 μg/ml) of Ge-132 for the whole culture period (days 0 to 7) during IVC on the developmental competence of IVF embryos was examined to determine the optimal concentration. The experiment was repeated five times. The total number of oocytes used per treatment group is presented in [Table 1](#tbl_001){ref-type="table"}. In experiment 2, the effect of Ge-132 treatment (0, 100, 200 and 400 μg/ml) during IVC on intracellular levels of GSH and ROS was investigated to determine cellular antioxidant potentials. This experiment was repeated three times (total GSH samples, N = 150; total ROS samples, N = 156). In experiment 3, we investigated the effects of Ge-132 treatment (0, 100, 200 and 400 μg/ml) on the mRNA expression of *POU5F1*, *CDX2*, *NRF2*, *KEAP1*, *BAX*, and *CASPASE3*. The experiments were repeated at least three times. Based on the results including developmental competence, intracellular GSH and ROS levels and gene expression, optimal Ge-132 concentration (200 μg/ml) for the *in vitro* development of porcine embryos was selected for the following apoptosis-related experiments. Experiment 4 and 5 was conducted to examine the effect of 200 μg/ml Ge-132 treatment during IVC on apoptotic index and apoptosis-related protein expression of KEAP1 and BCL2 in blastocysts using Annexin V/ PI assay and immunofluorescence analysis, respectively. The experiment was repeated three times.

Statistical analysis
--------------------

The statistical analyses were performed using SPSS 17.0 (SPSS, Chicago, IL, USA). A one-way analysis of variance followed by Duncan's multiple range tests with least significant difference was conducted to assess percentage data (e.g., cleavage, blastocyst formation, number of nuclei, cleavage pattern, blastocyst stage pattern, relative level or GSH and ROS, mRNA expression and derivation efficiency of ESCs); a Student's *t*-test was conducted to assess the apoptotic index. All results are expressed as the mean ± SEM. P values \< 0.05 were considered statistically significant, unless otherwise stated.

Results {#s2}
=======

Experiment 1: Developmental competence of porcine IVF embryos in chemically defined medium supplemented with different concentrations of Ge-132 during in vitro culture (IVC)
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

At day 2 after IVF, there were significantly higher number of 4- to 5-cell embryos in the 100- and 200- µg/ml Ge-132 groups than in the control groups. In addition, there were significantly less (P \< 0.05) fragmented embryos in the 100- and 200-µg/ml Ge-132 treatment groups than in the control group ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.Effect of various concentrations of Ge-132 treatment during *in vitro* culture (IVC) on the cleavage pattern of *in vitro* fertilization (IVF) embryos at day 2 (A) and the percentage of IVF embryos that developed to the blastocyst stage at day 7 (B). For each end point, bars with different letters (a--c) are significantly (P \< 0.05) different for different concentrations of Ge-132. EarBL, early blastocyst; ExpBL, expanded blastocyst; HatBL, hatched blastocyst. The experiment was replicated five times.). The embryonic developmental competence to the blastocyst stage after IVF was significantly (P \< 0.05) higher in the 100 µg/ml Ge-132 group (32.6%) than in the control group (26.5%) ([Table 2](#tbl_002){ref-type="table"}). All of the Ge-132 treatment groups displayed greater total cell numbers after IVC (98.1, 98.5 and 103.4, respectively) than the control group (73.9). As shown in [Fig 1B](#fig_001){ref-type="fig"}, hatched blastocyst formation on day 7 was significantly higher in the 100- and 200-µg/ml Ge-132 groups than the other groups.

Experiment 2: Effect of Ge-132 during in vitro culture (IVC) on intracellular levels of GSH and ROS in the IVF embryos
----------------------------------------------------------------------------------------------------------------------

To assess anti-oxidative effect of Ge-132, an analysis of intracellular GSH and ROS levels in the IVF embryos derived from the culture medium supplemented with Ge-132 was performed ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Epifluorescentphotomicrographic images of *in vitro* cultured porcine embryos. (A) Embryos were stained with CellTracker Blue (a--d) and 2', 7'-dichlorodihydrofluorescein diacetate (H2DCFDA) (e--h) to detect the intracellular levels of glutathione (GSH) and reactive oxygen species (ROS), respectively. Porcine embryos on day 2 at the 4- to 5-cell stages derived from the *in vitro* culture (IVC) medium supplemented with 0 µg/ml Ge-132 (a and e), 100 µg/ml Ge-132 (b and f), 200 µg/ml Ge-132 (c and g) and 400 µg/ml Ge-132 (d and h). (B) The relative levels of intracellular GSH and ROS in *in vitro* cultured porcine embryos among the four groups (0 µg/ml, 100 µg/ml, 200 µg/ml and 400 µg/ml Ge-132). Within each group end point (GSH and ROS), the bars with different letters (a--c) are significantly (P \< 0.05) different. The experiment was replicated three times.). The 200-μg/ml Ge-132 treatment group exhibited significantly increased (P \< 0.05) intracellular GSH levels compared with the control group. The ROS generation significantly decreased (P \< 0.05) as the Ge-132 concentrations increased.

Experiment 3: Effect of Ge-132 treatment during in vitro culture (IVC) on gene expression of IVF embryos
--------------------------------------------------------------------------------------------------------

To examine the effect of Ge-132 on the expression of inner cell mass (ICM) and trophectoderm (TE)-related genes, anti-oxidative-related and apoptosis-related genes, we evaluated the mRNA expression levels of *POU5F1*, *CDX2*, *NRF2*, *KEAP1*, *BAX*, and *CASPASE3* in the blastocysts of each group ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.mRNA expression levels (Mean ± SEM) of *POU5F1*, *CDX2*, *NRF2*, *KEAP1*, *BAX*, and *CASPASE3* in blastocysts treated with Ge-132 during *in vitro* culture (IVC). Within the same target mRNA, values with different superscript letters (a and b) are significantly (P \< 0.05) different. The experiment was replicated at least three times.). *CDX2* transcript levels were significantly lower in the blastocysts treated with all concentrations of Ge-132 (100, 200, and 400 μg/ml), although no difference was observed in the *POU5F1* transcript levels compared with the control (0 μg/ml Ge-132). The mRNA transcript levels of KEAP1 significantly decreased when Ge-132 concentrations increased (P \< 0.05) and expressed significantly lower in the 400 µg/ml Ge-132 group than control embryos (P \< 0.05). However, there were no significant differences in *NRF2* transcript levels among the groups under the same conditions. Furthermore, we also found that the 200 µg/ml Ge-132-treated embryos exhibited significantly lower mRNA expression levels of the pro-apoptotic gene *BAX* and *CASPASE3* compared with the control group (P \< 0.05).

Experiment 4: Effect of Ge-132 during in vitro culture (IVC) on the morphology and apoptosis rates in the IVF embryos
---------------------------------------------------------------------------------------------------------------------

Because ROS, which can induce the cell death \[[@r32]\], and mRNA expression levels of the pro-apoptotic genes were significantly reduced in Ge-132 treatment group, we hypothesized that the Ge-132 supplementation may impact apoptosis during *in vitro* culture of porcine embryos. To ascertain whether the Ge-132 is able to prevent apoptosis, we next evaluated apoptotic index in early (day 2) embryos ([Table 3](#tbl_003){ref-type="table"}). The Annexin V / PI staining showed that the early and late apoptotic index in the Ge-132 treated embryos were significantly lower than the untreated embryos (9.1 *vs.* 17.1% and 0 *vs.* 2.7%, respectively). Also, as shown in [Table 4](#tbl_004){ref-type="table"}Table 4.Effect of Ge-132 treatment to the IVC medium on the apoptotic index of Day 7 porcine blastocystsGroupNo. of blastocysts \* evaluatedNo. of blastomeres (apoptotic index \*\*, %)evaluatedapoptosisControl23169944 (2.5 ± 0.3) ^a^Ge-13223226635 (1.6 ± 0.3) ^b^\* Porcine blastocysts cultured with or without 200 µg/ml Ge-132 containing *in vitro* culture (IVC) medium. \*\* Apoptotic index, percentage of Annexin V-positivie /PI-negative cells in the blastocysts of each group. ^a,\ b^ Values with different superscripts within a column differ significantly (P \< 0.05). The experiment was repeated three times. The data represent the mean ± SEM., staining revealed significantly lower percentage of Annexin V-positive/PI-negative (apoptotic) cells in the day 7 blastocysts treated with 200 µg/ml Ge-132, compared to controls (1.6 *vs.* 2.5%).

Experiment 5: Effect of Ge-132 treatment during in vitro culture (IVC) on protein expression of IVF embryos
-----------------------------------------------------------------------------------------------------------

To further assess the involvement of the KEAP1 and BCL2 in Ge-132 treatment, we conducted immunofluorescence assay in blastocysts at day 7 ([Fig. 4](#fig_004){ref-type="fig"}Fig. 4.Effect of Ge-132 on the protein expression of KEAP1 and BCL2 in blastocysts treated with Ge-132 during *in vitro* culture (IVC). (A) Green fluorescence signals reveal KEAP1 protein localization, while red fluorescence signals showed BCL2 protein expression. The cells were counterstained with Hoechst (blue fluorescence) to visualize nuclear morphology. The white arrow indicates the absent of KEAP1 in nuclei (localization in cytosol). Each image shown is representative of at least 14 random fields observed. Indicated scale bars signify 100 µm distance. (B) The intensity of KEAP1 and BCL2 was quantitated by densitometric analysis and is shown in the histogram. The data is represented as the mean ± SD from three independent experiments. Within each group end point (KEAP1 and BCL2), the bars with different letters (a, b) are significantly (P \< 0.05) different.). The immunofluorescence staining showed that more KEAP1 protein was found to be localized in cytoplasm of the 200 μg/ml Ge-132 treated blastocysts, whereas KEAP1 protein was predominantly nuclei in the control blastocysts in agreement with the mRNA expression pattern in blastocysts ([Fig. 3](#fig_003){ref-type="fig"}). Also, significantly high BCL2 protein levels (P \< 0.05) could be detected in Ge-132 treated blastocysts compared to control blastocysts ([Fig. 4](#fig_004){ref-type="fig"}).

Discussion {#s3}
==========

This study of porcine embryo development revealed that appropriate concentrations of Ge-132 (1) decreased the percentage of fragmented embryos at day 2 and improved the blastocyst formation rate and mean number of cells in the blastocyst after fertilization *in vitro*, (2) increased intracellular GSH levels but decreased ROS levels in 4 to 5-cell stage embryos, (3) decreased the expression of *KEAP1* and the pro-apoptotic cascade genes such as *BAX* and *CASPASE3* and increased the expression of BCL2 in blastocysts, and (4) decreased the apoptosis in the IVF embryos.

The concept that a controlled redox system is essential for normal embryogenesis is further supported by the fact that dysregulation of the redox equilibrium severely interferes with embryo development \[[@r33]\]. Particularly, embryos under *in vitro* conditions are more sensitive to oxidative damage and inevitably exposed to oxidative stress generated by ROS, which act as second messengers by regulating key transcription factors associated with the oxidative process \[[@r34]\]. Furthermore, during this oxidative process, the GSH status in the rodent or porcine embryos is vital, considering that GSH is a major ROS-scavenging factor of the damaged cells and is related to the cell proliferation during embryonic event \[[@r35],[@r36],[@r37]\]. The reduced intracellular level of ROS and increased GSH level in the Ge-132-treated embryos on day 2 may indicate that the uncontrolled equilibrium of pro- and anti-oxidative processes under *in vitro* system, which can retard embryo development, may be regulated by Ge-132 supplementation.

Our previous study demonstrated that Ge-132 during IVM system has the capacity to act as ROS scavengers associated with nuclear factor (erythroid-derived 2) like 2 (NRF2)-regulated antioxidant pathway and protects porcine oocytes from damage caused by oxidative stress \[[@r23]\]. The *NRF2* is the key transcription factor that regulates many antioxidant genes in mammalian cell and is a well-known substrate of kelch-like ECH-associated protein 1 (KEAP1), which is an inhibitor of NRF2 \[[@r38]\]. Therefore, we speculated that Ge-132 supplementation during entire IVC system can facilitate the defense mechanism, particularly *NRF2*-dependent induction of GSH, against ROS and ameliorate the oxidative stress caused during early embryonic development, such as in the IVM system. However, we found that although *KEAP1* mRNA expression levels were lower in the Ge-132 treated embryos on day 7, there were no significant changes in *NRF2* mRNA expression levels compared with the control group. Using cues from other articles \[[@r39], [@r40]\], BCL2 has been reported as another substrate of KEAP1 instead of NRF2. The apoptotic pathways rely on a complex balance in the function of the BCL2 family \[[@r41]\], with anti-apoptotic (BCL-2, BCL-XL) and pro-apoptotic (BAX, BAK) members. The preimplantation embryos have a variety of the expression levels in the BCL2 family \[[@r42]\]. It was thought that KEAP1 under the normal *in vitro* condition of embryos facilitates Cul3-Rb1-mediated ubiquitination and degradation of BCL2 followed by the accumulation of BAX and the subsequent release of cytochrome C from mitochondrial membranes and activation of caspase 3, leading to apoptosis. In the present study, the more KEAP1 protein localization in cytoplasm and increased expression of BCL2 with Ge-132 treatment, directly indicating a coordinated inactivation of the KEAP1-regulated apoptotic pathway, which led to the regulation of a variety of apoptotic genes, such as the BCL2 family. Our data suggests the activities of the KEAP1-mediated mechanisms under Ge-132 treatment during the development of *in vitro* embryos. Under Ge-132 treatment, the down-regulation of KEAP1 induces the dissociation of BCL2, causing an increase in BCL2:BAX heterodimers, which is followed by a decrease in BAX, and subsequently reduced apoptosis and enhanced cell survival in *in vitro* embryos. These results support and extend recent studies showing that Ge-132 may simultaneously stimulate protection against oxidative stress and following apoptotic mechanisms that may be harmful to the development of embryos.

Cell death has been traditionally thought to be divided into two types, apoptosis and necrosis, which represent programmed cell death and accidental cell death, respectively \[[@r43], [@r44]\]. In many cells, including embryos, apoptosis performs the functions of regulating cell number and eliminating inappropriate or damaged cells, similar to necrosis \[[@r45], [@r46]\]. However, it should be strictly controlled to prevent inappropriate loss of normal cells. This regulation may be more aberrant in *in vitro* production embryos, due in part to the suboptimal culture conditions compared with the *in vivo* derived embryos. Furthermore, the cytoplasmic fragmentation of mammalian embryos is closely associated with both apoptosis and necrosis during preimplantation development \[[@r47], [@r48]\]. To provide direct evidence that Ge-132 plays an important role in apoptosis and fragmentation during embryo development, we observed the cleavage pattern and performed Annexin V/PI assay to evaluate apoptotic index in day 2 and day 7 embryos. The results support that Ge-132 treatment may reduce excessive apoptosis or necrosis, which may result in impaired cellular growth and embryo fragments in accordance with cleavage pattern data in this study. Although very little is known regarding the mechanism of Ge-132 related to apoptosis, according to a recent study, Ge-132 can interact with physiological *cis*-diol compounds, such as adenosine triphosphate (ATP), and form complexes \[[@r49]\]. Intracellular ATP levels appear to be a factor that determines cell death fate by apoptosis and necrosis \[[@r50]\]. Most of the fragmented blastomeres indicate depletion of ATP, which is one of the characteristics of necrotic cells that exhibit mitochondrial deficiency \[[@r51]\]. However, a higher proportion of organogermanium 3-(trihydroxygermyl) propanoic acid (THGPA), which is a hydrolysate of Ge-132, may be present in the extracellular space compared with in the intracellular fluid because it may not be readily incorporated into intercellular compartments. Therefore, the ATP chelating effect of THGPA may be involved not in intracellular ATP but in extracellular ATP (eATP). This suggests that a similar underlying mechanism that chelate formation between Ge-132 and eATP may reduce apoptosis under excessive ATP supplying conditions during *in vitro* development of embryos may be a possible explanation for the anti-apoptotic effect of Ge-132 \[[@r52], [@r53]\]. One caveat that should be taken into consideration is a possible reduction with time in the intracellular ATP of the embryos. To answer whether Ge-132 treatment is involved in intracellular ATP will require further investigation.

Down-regulation of *CDX2* leads to asymmetric divisions, thereby contributing to the ICM, whereas up-regulation of *CDX2* promotes symmetric divisions and consequently contribution to the TE \[[@r45]\]. Interestingly, although the mRNA expression level of *CDX2* was decreased and there were no significant changes in the mRNA levels of *POU5F1* in response to any of the treatments used here, all of the Ge-132 treated groups exhibited increased total cell numbers in the blastocysts. These results suggested that treatment of Ge-132 during porcine IVC might affect ICM and TE quality. Evidence from another study from mouse embryos also indicated that the total cell number remained unchanged upon *CDX2* depletion \[[@r54]\]. In addition, the apoptotic cells were increased in a *CDX2*-deficient blastocyst. However, the results of this study support the anti-apoptotic effect of Ge-132. Thus, we postulate that Ge-132 overcomes the apoptotic impact caused by the down-regulated *CDX2* activating KEAP1-BCL2 system. There are many grading systems to evaluate blastocysts including the degree of expansion of the cavity and whether or not it has started to \"hatch\" or breaking of the ZP. *In vivo*, a blastocyst hatches on day 6 or 7 after fertilization. Failure to "hatch" has been attributed to zona hardening and suboptimal culture conditions \[[@r55]\]. In this study, 100- and 200-µg/ml Ge-132 not only decreased the fragmentation rate on day 2, but also improved the percentage of hatched blastocysts on day 7 compared to the control group. Based on these results, 100- and 200-µg/ml Ge-132 might be optimal concentrations for development of porcine embryos. Also, the derivation efficiency of ESC might be another tool to evaluate blastocysts indirectly \[[@r56]\]. Some reports have shown that reducing oxidant stress increased the success of establishing new mouse and porcine ESC lines \[[@r57], [@r58]\]. Although further experiments need to be conducted, the putative porcine ESC lines were derived from 100- and 200-µg/ml Ge-132 treatment group and showed a similar derivation process with primed ESCs, such as previously reported porcine ESC lines \[[@r59]\] as shown in [Supplementary Table 1](#pdf_001){ref-type="supplementary-material"} and [Supplementary Fig. 1](#pdf_001){ref-type="supplementary-material"} (online only). These newly derived porcine ESC lines may be used as sources for further rigorous analyses on the role of Ge-132 during the specification of cell fate and differentiation.

In summary, our results suggest that Ge-132 supplementation during development of porcine early *in vitro*-fertilized embryos is highly efficient, highlighting the ability of Ge-132 to activate the apoptosis defense mechanism, which is primarily driven by the KEAP1-associated anti-apoptotic pathway. To our knowledge, the present study demonstrates for the first time a critical role for KEAP1-dependent BCL2-induced signaling in porcine embryo development against oxidative stress. Overall, these findings provide a new and comprehensive information and in-depth insight into the molecular mechanisms of Ge-132 that confers anti-oxidative and anti-apoptotic protection during *in vitro* development model.
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